Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

How visual stimulus effects the time perception? The evidence from time perception of emotional videos.

Özgör C, Şenyer Özgör S, Duru AD, Işoğlu-Alkaç Ü.

Cogn Neurodyn. 2018 Aug;12(4):357-363. doi: 10.1007/s11571-018-9480-6. Epub 2018 Feb 9.

PMID:
30137872
2.

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma.

Lund J, Gruber A, Lauri B, Duru AD, Blimark C, Swedin A, Hansson M, Forsberg K, Ahlberg L, Carlsson C, Waage A, Gimsing P, Vangsted AJ, Frølund U, Holmberg E, Gahrton G, Alici E, Hardling M, Mellqvist UH, Nahi H.

Cancer Med. 2018 Jun;7(6):2256-2268. doi: 10.1002/cam4.1422. Epub 2018 Apr 19.

3.

Editorial Comment on: Utilizing Machine Learning and Automated Performance Metrics to Evaluate Robot-Assisted Radical Prostatectomy Performance and Predict Outcomes by Hung et al.

Atug F, Sanli O, Duru AD.

J Endourol. 2018 May;32(5):445. doi: 10.1089/end.2018.0209. Epub 2018 Apr 26. No abstract available.

PMID:
29631446
4.

The Immunogenicity of a Proline-Substituted Altered Peptide Ligand toward the Cancer-Associated TEIPP Neoepitope Trh4 Is Unrelated to Complex Stability.

Hafstrand I, Doorduijn EM, Sun R, Talyzina A, Sluijter M, Pellegrino S, Sandalova T, Duru AD, van Hall T, Achour A.

J Immunol. 2018 Apr 15;200(8):2860-2868. doi: 10.4049/jimmunol.1700228. Epub 2018 Mar 5.

PMID:
29507106
5.

Investigating neural efficiency of elite karate athletes during a mental arithmetic task using EEG.

Duru AD, Assem M.

Cogn Neurodyn. 2018 Feb;12(1):95-102. doi: 10.1007/s11571-017-9464-y. Epub 2017 Dec 4.

PMID:
29435090
6.

Crystal structures of H-2Db in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and immunogenicity.

Hafstrand I, Badia-Martinez D, Josey BJ, Norström M, Buratto J, Pellegrino S, Duru AD, Sandalova T, Achour A.

PLoS One. 2017 Dec 18;12(12):e0189584. doi: 10.1371/journal.pone.0189584. eCollection 2017.

7.

Lipid-based Transfection Reagents Exhibit Cryo-induced Increase in Transfection Efficiency.

Sork H, Nordin JZ, Turunen JJ, Wiklander OP, Bestas B, Zaghloul EM, Margus H, Padari K, Duru AD, Corso G, Bost J, Vader P, Pooga M, Smith CE, Wood MJ, Schiffelers RM, Hällbrink M, Andaloussi SE.

Mol Ther Nucleic Acids. 2016 Mar 8;5:e290. doi: 10.1038/mtna.2016.8.

8.

The MHC Class I Cancer-Associated Neoepitope Trh4 Linked with Impaired Peptide Processing Induces a Unique Noncanonical TCR Conformer.

Hafstrand I, Doorduijn EM, Duru AD, Buratto J, Oliveira CC, Sandalova T, van Hall T, Achour A.

J Immunol. 2016 Mar 1;196(5):2327-34. doi: 10.4049/jimmunol.1502249. Epub 2016 Jan 22.

9.

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.

Dahlberg CI, Sarhan D, Chrobok M, Duru AD, Alici E.

Front Immunol. 2015 Nov 30;6:605. doi: 10.3389/fimmu.2015.00605. eCollection 2015. Review.

10.

Autologous Peripheral Blood Mononuclear Cells as Treatment in Refractory Acute Respiratory Distress Syndrome.

Jungebluth P, Holzgraefe B, Lim ML, Duru AD, Lundin V, Heldring N, Wiklander OP, Nordin JZ, Chrobok M, Roderburg C, Sjöqvist S, Anderstam B, Beltrán Rodríguez A, Haag JC, Gustafsson Y, Roddewig KG, Jones P, Wood MJ, Luedde T, Teixeira AI, Hermanson O, Winqvist O, Kalzén H, El Andaloussi S, Alici E, Macchiarini P.

Respiration. 2015;90(6):481-92. doi: 10.1159/000441799. Epub 2015 Nov 28.

11.

Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach.

Alici E, Chrobok M, Lund J, Ahmadi T, Khan I, Duru AD, Nahi H.

Br J Haematol. 2016 Aug;174(3):473-7. doi: 10.1111/bjh.13776. Epub 2015 Oct 12. No abstract available.

PMID:
26455823
12.

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma.

Duru AD, Sutlu T, Wallblom A, Uttervall K, Lund J, Stellan B, Gahrton G, Nahi H, Alici E.

PLoS One. 2015 Sep 17;10(9):e0138248. doi: 10.1371/journal.pone.0138248. eCollection 2015.

13.

Analysis of correlation between white matter changes and functional responses in thalamic stroke: a DTI & EEG study.

Duru AD, Duru DG, Yumerhodzha S, Bebek N.

Brain Imaging Behav. 2016 Jun;10(2):424-36. doi: 10.1007/s11682-015-9397-1.

PMID:
25957181
14.

Improvement of design of a surgical interface using an eye tracking device.

Erol Barkana D, Açık A, Duru DG, Duru AD.

Theor Biol Med Model. 2014 May 7;11 Suppl 1:S4. doi: 10.1186/1742-4682-11-S1-S4. Epub 2014 May 7. Erratum in: Theor Biol Med Model. 2014;11:48. Duru, Dilek Goksel [added]; Duru, Adil Deniz [added].

15.

The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment.

Uttervall K, Duru AD, Lund J, Liwing J, Gahrton G, Holmberg E, Aschan J, Alici E, Nahi H.

PLoS One. 2014 Jul 8;9(7):e101819. doi: 10.1371/journal.pone.0101819. eCollection 2014.

16.

Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.

Allerbring EB, Duru AD, Uchtenhagen H, Madhurantakam C, Tomek MB, Grimm S, Mazumdar PA, Friemann R, Uhlin M, Sandalova T, Nygren PÅ, Achour A.

Eur J Immunol. 2012 Nov;42(11):2990-3000. doi: 10.1002/eji.201242588. Epub 2012 Sep 20.

17.

Inflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complex.

Madhurantakam C, Duru AD, Sandalova T, Webb JR, Achour A.

PLoS One. 2012;7(3):e32805. doi: 10.1371/journal.pone.0032805. Epub 2012 Mar 14.

18.

Investigaton of the neuronal efficacy and EEG source power under steady-state visual stimulation.

Duru AD, Erdogan SB, Kasikci I, Bayram A, Ademoglu A, Demiralp T.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:6576-9. doi: 10.1109/IEMBS.2011.6091622.

PMID:
22255846
19.

Simultaneous EEG/fMRI analysis of the resonance phenomena in steady-state visual evoked responses.

Bayram A, Bayraktaroglu Z, Karahan E, Erdogan B, Bilgic B, Ozker M, Kasikci I, Duru AD, Ademoglu A, Oztürk C, Arikan K, Tarhan N, Demiralp T.

Clin EEG Neurosci. 2011 Apr;42(2):98-106.

PMID:
21675599
20.

Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice.

Brodin P, Lakshmikanth T, Mehr R, Johansson MH, Duru AD, Achour A, Salmon-Divon M, Kärre K, Höglund P, Johansson S.

PLoS One. 2010 Oct 4;5(10). pii: e13174. doi: 10.1371/journal.pone.0013174.

21.

Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.

Kavak E, Najafov A, Ozturk N, Seker T, Cavusoglu K, Aslan T, Duru AD, Saygili T, Hoxhaj G, Hiz MC, Unal DO, Birgül-Iyison N, Ozturk M, Koman A.

Cell Signal. 2010 Oct;22(10):1523-35. doi: 10.1016/j.cellsig.2010.05.021. Epub 2010 Jun 9.

PMID:
20538055
22.

Implementation of low resolution electro-magnetic tomography with FMRI statistical maps on realistic head models.

Duru AD, Eryilmaz H, Emir U, Bayraktaroglu Z, Demiralp T, Ademoglu A.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:5239-42.

PMID:
18003189
23.

Neuroimaging of event related brain potentials (ERP) using fMRI and dipole source reconstruction.

Eryilmaz HH, Duru AD, Parlak B, Ademoglu A, Demiralp T.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:3384-7.

PMID:
18002723
24.

Source localization of subtopographic brain maps for event related potentials (ERP).

Duru AD, Bayram A, Demiralp T, Ademoglu A.

Conf Proc IEEE Eng Med Biol Soc. 2006;1:4832-4.

PMID:
17946655
25.

Triticum durum metallothionein. Isolation of the gene and structural characterization of the protein using solution scattering and molecular modeling.

Bilecen K, Ozturk UH, Duru AD, Sutlu T, Petoukhov MV, Svergun DI, Koch MH, Sezerman UO, Cakmak I, Sayers Z.

J Biol Chem. 2005 Apr 8;280(14):13701-11. Epub 2005 Jan 4.

Supplemental Content

Support Center